NASDAQ:HBIO - Nasdaq - US4169061052 - Common Stock - Currency: USD
TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
Net Income | -14.24M | -3.42M | -9.52M | -290.00K | -7.81M | |||
Depreciation Amortization | 7.17M | 7.00M | 7.57M | 7.62M | 7.63M | |||
Income Taxes - Deferred | N/A | 336.00K | -410.00K | -330.00K | -140.00K | |||
Change In Working Capital | 3.05M | 4.60M | 2.72M | -10.19M | 4.11M | |||
Interest Paid | 3.15M | 3.79M | 2.31M | 1.58M | 4.88M | |||
Taxes Paid | 352.00K | 207.00K | 530.00K | 580.00K | 420.00K | |||
Other non cash items | 8.15M | 5.51M | 790.00K | 4.45M | 5.55M | |||
OPERATING CASH FLOW | 4.01M | 14.03M | 1.15M | 1.26M | 9.33M | |||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
Capital Expenditure | -3.86M | -2.31M | -1.59M | -1.35M | -1.15M | |||
Other Investing Activity | 1.92M | 512.00K | N/A | N/A | -250.00K | |||
INVESTING CASH FLOW | -1.94M | -1.80M | -1.59M | -1.35M | -1.40M | |||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
Debt Issued/Reduced | -1.02M | -10.54M | -1.79M | 50.00K | -5.60M | |||
Stock Issued/Repurchased | 429.00K | 930.00K | 580.00K | 3.31M | N/A | |||
Other Financing Activity | -2.29M | -2.52M | -1.63M | -3.62M | -2.37M | |||
FINANCING CASH FLOW | -2.89M | -12.13M | -2.84M | -250.00K | -7.97M | |||
Exchange Rate Effect | 43.00K | -320.00K | -40.00K | -160.00K | 20.00K | |||
CHANGE IN CASH | -769.00K | -225.00K | -3.32M | -500.00K | -20.00K | |||
FREE CASH FLOW | ||||||||
Operating Cash Flow | 4.01M | 14.03M | 1.15M | 1.26M | 9.33M | |||
Capital Expenditure | -3.86M | -2.31M | -1.59M | -1.35M | -1.15M | |||
FREE CASH FLOW | 155.00K | 11.72M | -440.00K | -90.00K | 8.18M |
All data in USD